Evidence map›Paper›PMID 40290806›Full record

ReviewBiochemistry and biophysics reports2025

Pterostilbene and resveratrol: Exploring their protective mechanisms against skin photoaging - A scoping review.

Raveena Vaidheswary Muralitharan, Siti Fathiah Masre, Dayang Fredalina Basri, Ahmad Rohi Ghazali

Abstract readReview
In one paragraph

Review in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Raveena Vaidheswary MuralitharanCenter for Toxicology and Health Risk Studies (CORE), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Siti Fathiah MasreCenter for Toxicology and Health Risk Studies (CORE), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Dayang Fredalina BasriCenter for Diagnostic, Therapeutic and Investigative Studies (CODTIS), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Ahmad Rohi GhazaliCenter for Toxicology and Health Risk Studies (CORE), Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prolonged ultraviolet (UV) exposure depletes the skin's endogenous antioxidants, leading to photoaging. Exogenous antioxidants are essential to counter this, with stilbenes such as pterostilbene and resveratrol emerging as promising candidates due to their antioxidant, anti-inflammatory and anti-cancer properties. The current scoping review presents an overview of the evidence on the effects of pterostilbene and resveratrol on skin photoaging. A literature search was conducted using PubMed, Scopus, and Web of Science databases in April 2025. Original research articles that investigated the effects of pterostilbene and resveratrol on skin photoaging in cells, animals, or humans were included. 9 eligible articles were included in this review. The findings suggest that resveratrol significantly improves skin photoaging, while preliminary evidence indicates that pterostilbene may offer advantages over resveratrol. However, due to the limited research on pterostilbene, further studies are required to confirm its efficacy. Key considerations in establishing valid in vitro and in vivo models, alongside macroscopic and histologic features of photoaging, were also discussed. In conclusion, while resveratrol shows significant promise in combating skin photoaging, pterostilbene is still in the early exploration phases. Advancing to human trials is crucial to confirm the efficacy of these stilbenes in preventing and treating photoaging.

Indexed as

PhotoagingPterostilbeneResveratrolSkin

Identifiers

PMID40290806
PMCPMC12022656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.